Pulmonary TB: Clinical Trials

3 trials for Pulmonary TB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Active not recruiting 1
Phase 11Completed 1

Follow Pulmonary TB: new trials by email Literature Review of Pulmonary TB trials Research Report on Pulmonary TB

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis
sorfequiline, Pretomanid, Linezolid - Pulmonary TB, Pulmonary Tuberculosis
Phase 2Active not recruitingGlobal Alliance for TB Drug Development3092023-10-312026-06-24
Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
Delamanid, Bedaquiline, RHEZ - Pulmonary TB
Phase 2CompletedOtsuka Pharmaceutical Development & Commercialization, Inc.1222022-04-122026-08-12
A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis
10 mg OPC-167832, 30 mg OPC-167832, 90 mg OPC-167832 - Pulmonary TB
Phase 1 / Phase 2CompletedOtsuka Pharmaceutical Development & Commercialization, Inc.1222018-10-182023-11-18

Narrower conditions

Tuberculosis, Pulmonary (3)  ·  Tuberculosis (1)

Broader conditions

Actinomycetales Infections (3)  ·  Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Gram-Positive Bacterial Infections (3)  ·  Infections (3)  ·  Lung Diseases (3)  ·  Mycobacterium Infections (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Tuberculosis (2)

Interventions

Isoniazid (2)  ·  OPC-67683 (2)  ·  Rifampin (2)  ·  bedaquiline (2)  ·  Ethambutol (1)  ·  Linezolid (1)  ·  Protons (1)  ·  Pyrazinamide (1)  ·  TBAJ-876 (1)  ·  pretomanid (1)

Sponsors

Otsuka Pharmaceutical Development & Commercialization, Inc. (2)  ·  Global Alliance for TB Drug Development (1)

Countries

South Africa (3)  ·  Georgia (1)  ·  Philippines (1)  ·  Tanzania (1)  ·  Uganda (1)

Top investigators

Morounfolu Olugbosi, MD (1)  ·  Prof. Andreas Diacon (1)  ·  Prof. Rodney Dawson, MD (1)  ·  Veronique R de Jager, MD (1)

Results publications

PMID 38243296, PMID 39612928, PMID 39651910, PMID 41121745, PMID 41616265, PMID 42214407